Biotech employee charged with insider trading ahead of company's drug announcement
MLex Summary: The US Securities and Exchange Commission on Thursday charged the former senior director of regulatory affairs for Puma Biotechnology, Robert Gadimian, with insider trading ahead of the company’s news announcements...To view the full article, register now.
Already a subscriber? Click here to view full article